Anzeige
Mehr »
Login
Mittwoch, 04.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Analysten eilen, um Kursziele zu verdreifachen nach ATHAs neuester Entdeckung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CTVL | ISIN: US81948W1045 | Ticker-Symbol: N/A
Frankfurt
21.10.24
15:29 Uhr
1,300 Euro
0,000
0,00 %
1-Jahres-Chart  (nicht börsennotiert)
SHARECARE INC Chart 1 Jahr
GlobeNewswire (Europe)
132 Leser
Artikel bewerten:
(0)

Sharecare, Inc.: Sharecare announces inducement grants under Nasdaq Listing Rule 5635(c)(4)

Finanznachrichten News

ATLANTA, June 19, 2024 (GLOBE NEWSWIRE) -- Sharecare (NASDAQ: SHCR), the digital health company that helps people manage all their health in one place, today announced that on June 14, 2024, its Board of Directors (the "Board") adopted the Sharecare, Inc. 2024 Inducement Plan (the "Inducement Plan"), under which the Company may grant inducement equity awards outside of the Sharecare, Inc. 2021 Omnibus Incentive Plan, as amended. The Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of the Company (or following a bona fide period of non-employment) as an inducement material to such individuals entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The Company allocated up to 5,000,000 shares of common stock of the Company to be subject to inducement equity awards under the Inducement Plan.

In addition, the Company announced that effective June 14, 2024, the Board has granted inducement equity awards under the Inducement Plan to five new employees. The five employees received a total of 3,389,285 restricted stock units, 1,889,285 of which are time-based restricted stock units ("RSUs") and 1,500,000 of which are performance-based restricted stock units ("PSUs"). The RSUs vest over three or four years, subject to each employee's continuous employment on each vesting date. The PSUs granted to one of the new employees provide for cliff vesting at the end of the three-year performance period, with the number of shares to be issued based on annual achievement of defined performance-based vesting conditions and will be subject to the employee's continuous employment through the vesting date. Other terms of the RSU and PSU grants and any additional grants under the Inducement Plan are as determined by the Board or Compensation Committee and are as set forth in the Inducement Plan and applicable award agreements covering each grant.

For more information, visit investors.sharecare.com.

About Sharecare
Sharecare is the leading digital health company that helps people - no matter where they are in their health journey - unify and manage all their health in one place. Our comprehensive and data-driven virtual health platform is designed to help people, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving positive behavior change. Driven by our philosophy that we are all together better, at Sharecare, we are committed to supporting each individual through the lens of their personal health and making high-quality care more accessible and affordable for everyone. To learn more, visit www.sharecare.com.

Contacts:
Media: pr@sharecare.comInvestors: investors@sharecare.com

© 2024 GlobeNewswire (Europe)
5 heiße Wetten für den Jahresendspurt!
Nach dem unerwartet schnellen Ende der US-Wahlen mit dem Sieg des republikanischen Kandidaten Donald Trump fackelten die Aktien- und Krypto- Märkte ein wahres Kursfeuerwerk ab und bliesen zur Jahresendrallye.

Im aktuellen kostenlosen Report beleuchten wir 5 aussichtsreiche Unternehmen, die das Fundament besitzen, in den nächsten Monaten den breiten Markt zu schlagen.

Seien Sie dabei!

Fordern Sie jetzt unseren brandneuen neuen Spezialreport an und erfahren Sie, welche Aktien aufgrund ihrer Bewertung sowie charttechnischen Situation das Potenzial zu einer Outperformance besitzen.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.